Sundaram Multi Pap Withdraws ₹235.90 Crore Preferential Issue After SLAPL Exit

2 min read     Updated on 05 Mar 2026, 12:27 PM
scanx
Reviewed by
Naman SScanX News Team
Overview

Sundaram Multi Pap Limited has officially withdrawn its proposed preferential issue worth ₹235.90 crore following a board meeting on March 5, 2026. The withdrawal came after Sundaram Land and Assets Private Limited (SLAPL) communicated its exit from the share swap transaction on February 27, 2026, citing significant market deterioration that saw the company's share price decline by 54.63% from the original swap price of ₹3.35 to ₹1.52 per share.

33818030

*this image is generated using AI for illustrative purposes only.

Sundaram Multi Pap Limited has formally withdrawn its proposed preferential issue of 7,04,00,000 equity shares following the board meeting held on March 5, 2026. The decision came after Sundaram Land and Assets Private Limited (SLAPL) communicated its withdrawal from the share swap transaction on February 27, 2026, citing material changes in prevailing market conditions.

Board Meeting Outcome and Decision

The board meeting, which commenced at 11:00 AM and concluded at 12:00 Noon on March 5, 2026, was held at the company's premises in Andheri East, Mumbai. During the meeting, directors considered SLAPL's communication and resolved not to proceed further with the proposed preferential issue that was originally approved by shareholders at the Extraordinary General Meeting held on November 12, 2025.

Meeting Details: Information
Date: March 5, 2026
Commencement Time: 11:00 AM
Conclusion Time: 12:00 Noon
Venue: 5/6 Papa Industrial Estate, Suren Road, Andheri (East)
Chairman & Managing Director: Amrut P Shah
DIN: 00033120

Original Transaction Structure

The proposed transaction involved the issuance of 7,04,00,000 equity shares at ₹3.35 per share, with a total transaction value of ₹235.90 crore. Through this share swap mechanism, Sundaram Multi Pap intended to acquire a 52.38% stake in SLAPL. The transaction had received shareholder approval at the Extraordinary General Meeting conducted on November 12, 2025.

Transaction Parameters: Details
Share Issue: 7,04,00,000 equity shares
Issue Price: ₹3.35 per share
Total Value: ₹235.90 crore
Intended Stake: 52.38% in SLAPL
EGM Approval: November 12, 2025
Current Status: Withdrawn

Market Conditions and Withdrawal Rationale

SLAPL's withdrawal was primarily attributed to the substantial decline in Sundaram Multi Pap's share price, which dropped from the originally proposed swap price of ₹3.35 per share to ₹1.52 per share as of February 27, 2026. This represented a decline of ₹1.83 per share, or 54.63%, over the 107-day period since the EGM approval.

Price Impact Analysis: Amount
Original Swap Price: ₹3.35 per share
Market Price (Feb 27): ₹1.52 per share
Price Decline: ₹1.83 per share
Percentage Decline: 54.63%
Period: 107 days since EGM

Regulatory Compliance and Communication

The company has maintained full compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, throughout the process. Chairman & Managing Director Amrut Premji Shah signed the official communication to BSE Limited and National Stock Exchange of India Limited, informing them of the board meeting outcome. SLAPL had cited delays in obtaining requisite approvals and the material reduction in economic value as key factors in their decision to withdraw from the transaction.

The formal withdrawal of this preferential issue represents a significant shift in the company's expansion strategy and may require reassessment of its growth plans involving strategic partnerships and acquisitions.

Historical Stock Returns for Sundaram Multi Pap

1 Day5 Days1 Month6 Months1 Year5 Years
+0.83%-5.47%-25.31%-38.89%-41.26%-10.37%

Sundaram Multi Pap Limited Board Approves Q3 FY26 Unaudited Standalone Financial Results

1 min read     Updated on 14 Feb 2026, 07:56 PM
scanx
Reviewed by
Naman SScanX News Team
Overview

Sundaram Multi Pap Limited successfully conducted its board meeting on February 14, 2026, approving unaudited standalone financial results for Q3 FY26 and nine months ended December 31, 2025. The meeting was presided over by Chairman & Managing Director Amrut P Shah and fulfilled all regulatory requirements under SEBI Regulation 33, with formal communications sent to BSE and NSE.

32605334

*this image is generated using AI for illustrative purposes only.

Sundaram Multi Pap Limited has announced the successful completion of its board meeting held on February 14, 2026, where key financial results were approved for the third quarter of fiscal year 2026. The meeting took place at the company's premises located at 5/6 Papa Industrial Estate, Suren Road, Andheri (East), Mumbai, spanning three hours from 11:00 AM to 2:00 PM.

Board Meeting Details and Venue

The board meeting was conducted under the leadership of Chairman & Managing Director Amrut P Shah, who holds DIN 00033120. The meeting was held in compliance with regulatory requirements and followed the intimation submitted to stock exchanges on February 6, 2026.

Meeting Parameter: Details
Date: February 14, 2026
Commencement Time: 11:00 AM
Conclusion Time: 2:00 PM
Venue: 5/6 Papa Industrial Estate, Suren Road, Andheri (East), Mumbai 400093
Presiding Officer: Amrut P Shah, Chairman & Managing Director

Financial Results Approval

The primary agenda of the board meeting focused on the consideration and approval of unaudited standalone financial results. The directors approved the financial performance data for both the quarter and nine months ended December 31, 2025, marking the completion of Q3 FY26 reporting requirements.

The financial results were prepared in accordance with applicable accounting standards and were accompanied by a Limited Review Report issued by the company's auditors. This approval ensures compliance with Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Regulatory Compliance and Documentation

The company has fulfilled its regulatory obligations by formally communicating the board meeting outcome to both BSE Limited and National Stock Exchange of India Limited. The communication was digitally signed by Chairman & Managing Director Amrut P Shah on February 14, 2026, at 14:09:27 +05'30', ensuring proper documentation and timestamp verification.

Exchange Details: Information
BSE Scrip Code: 533166
NSE Symbol: SUNDARAM
Regulation Reference: SEBI Regulation 33
Reporting Period: Quarter and nine months ended December 31, 2025

The approval of these unaudited standalone financial results represents a significant milestone in the company's quarterly reporting cycle, providing stakeholders with updated financial information for the third quarter and nine-month period of fiscal year 2026.

Historical Stock Returns for Sundaram Multi Pap

1 Day5 Days1 Month6 Months1 Year5 Years
+0.83%-5.47%-25.31%-38.89%-41.26%-10.37%

More News on Sundaram Multi Pap

1 Year Returns:-41.26%